Scenic Biotech Enables Identification of Genetic Modifiers Easy with its Cell-Seq Platform
Scenic Biotech’s proprietary Cell-Seq platform offers the opportunity to systemically explore genetic modifiers independent of prevalence by mimicking population genetics in a petri dish, states Oscar Izeboud, CEO, Scenic Biotech in an engaging session with Aishwarya Saxena, Pharma Industrial India.
Scenic Biotech | 04/06/2024
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy